SOX2 recruits KLF4 to regulate nasopharyngeal carcinoma proliferation via PI3K/AKT signaling

被引:0
|
作者
Jianming Tang
Guansheng Zhong
Jianhui Wu
Haiyan Chen
Yongshi Jia
机构
[1] People’s Hospital of Hangzhou Medical College,Department of Radiation Oncology, Zhejiang Provincial People’s Hospital
[2] People’s Hospital of Hangzhou Medical College,Department of Thyroid and Breast Surgery, Zhejiang Provincial People’s Hospital
[3] Meizhou People’s Hospital,Department of The Otolaryngology
[4] The Second Affiliated Hospital of Zhejiang University School of Medicine,Department of Radiation Oncology
来源
Oncogenesis | / 7卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
SOX2 is a transcription factor that contributes to transcription modification and cancer, but the mechanism by which SOX2 regulates nasopharyngeal carcinoma cell proliferation is not well understood. Here, we identify a SOX2 signaling pathway that facilitates nasopharyngeal carcinoma, where it is upregulated. SOX2 expression was associated with nasopharyngeal carcinoma patient survival. SOX2 knockdown inhibited cell proliferation, colony formation, and tumorigenesis in an subcutaneous mouse xenograft model system. Six hundred and ninety-nine candidate SOX2 downstream dysregulated genes were identified in nasopharyngeal carcinoma cells through cDNA microarray analysis. SOX2 recruited the nuclear transcription factor KLF4 to bind to the PIK3CA promoter upregulate PIK3CA expression, acting to enhance PI3K/AKT signaling and tumorigenesis by upregulating PIK3CA expression. Besides, overexpressing activated AKT or PIK3CA rescued the growth inhibition of cells due to SOX2 knockdown. Together, our study suggest that SOX2 exhibits oncogenic properties and may be a reliable molecular biomarker in nasopharyngeal carcinoma. Targeting SOX2 might be a promising treatment strategy for nasopharyngeal carcinoma treatment.
引用
收藏
相关论文
共 50 条
  • [31] Histone deacetylase inhibitors regulate the oral cancer via PI3K/AKT signaling pathway
    Govindarasu, Mydhili
    Prathap, Lavanya
    Govindasamy, Rajakumar
    ORAL ONCOLOGY, 2022, 135
  • [32] SOX2 knockdown inhibits the migration and invasion of basal cell carcinoma cells by targeting the SRPK1-mediated PI3K/AKT signaling pathway
    Li, Zhuo-Ran
    Jiang, Yong
    Hu, Jian-Zhong
    Chen, Yang
    Liu, Quan-Zhong
    ONCOLOGY LETTERS, 2019, 17 (02) : 1617 - 1625
  • [33] RBP4 regulates trophoblastic cell proliferation and invasion via the PI3K/AKT signaling pathway
    Li, Hongxia
    Cao, Guangming
    Zhang, Nawei
    Lou, Tong
    Wang, Qiushi
    Zhang, Zhenyu
    Liu, Chongdong
    MOLECULAR MEDICINE REPORTS, 2018, 18 (03) : 2873 - 2879
  • [34] ERBB4 promotes the proliferation of gastric cancer cells via the PI3K/Akt signaling pathway
    Xu, Ji
    Gong, Lijie
    Qian, Zhenyuan
    Song, Guangyuan
    Liu, Jinming
    ONCOLOGY REPORTS, 2018, 39 (06) : 2892 - 2898
  • [35] The role of PI3K/AKT signaling pathway in gallbladder carcinoma
    Wu, Zeyu
    Yu, Xiao
    Zhang, Shuijun
    He, Yuting
    Guo, Wenzhi
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2022, 14 (07): : 4426 - 4442
  • [36] The Role of PI3K/Akt/mTOR Signaling in Gastric Carcinoma
    Matsuoka, Tasuku
    Yashiro, Masakazu
    CANCERS, 2014, 6 (03) : 1441 - 1463
  • [37] Small biomarkers with massive impacts: PI3K/AKT/mTOR signalling and microRNA crosstalk regulate nasopharyngeal carcinoma
    Li, Hai-Long
    Deng, Nian-Hua
    He, Xiu-Sheng
    Li, Yue-Hua
    BIOMARKER RESEARCH, 2022, 10 (01)
  • [38] Small biomarkers with massive impacts: PI3K/AKT/mTOR signalling and microRNA crosstalk regulate nasopharyngeal carcinoma
    Hai-Long LI
    Nian-Hua Deng
    Xiu-Sheng He
    Yue-Hua Li
    Biomarker Research, 10
  • [39] Cell Proliferation and Apoptosis-Related Genes Affect the Development of Human Nasopharyngeal Carcinoma Through PI3K/AKT Signaling Pathway
    Li, Wei
    Ma, Huiping
    Liu, Minglei
    MOLECULAR BIOTECHNOLOGY, 2021, 63 (11) : 1081 - 1091
  • [40] ANLN, Regulated by SP2, Promotes Colorectal Carcinoma Cell Proliferation via PI3K/AKT and MAPK Signaling Pathway
    Liu, Yanwei
    Cao, Pengwei
    Cao, Feng
    Wang, Song
    He, Yan
    Xu, Yanyan
    Wang, Yong
    JOURNAL OF INVESTIGATIVE SURGERY, 2022, 35 (02) : 268 - 277